These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 7481069)
1. Effects of enalapril treatment on gene expression of smooth muscle myosin heavy chain isoforms in glomeruli of diabetic rats. Nakamura T; Ebihara I; Fukui M; Makita Y; Tomino Y; Kimura K; Nagai R; Yazaki Y; Koide H Ren Physiol Biochem; 1995; 18(4):183-90. PubMed ID: 7481069 [TBL] [Abstract][Full Text] [Related]
2. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis. Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620 [TBL] [Abstract][Full Text] [Related]
3. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats. Nakamura T; Kimura K; Ebihara I; Takahashi T; Tomino Y; Aikawa M; Yazaki Y; Nagai R; Koide H Clin Sci (Lond); 1995 Jul; 89(1):45-52. PubMed ID: 7671567 [TBL] [Abstract][Full Text] [Related]
4. Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli. Fukui M; Nakamura T; Ebihara I; Makita Y; Osada S; Tomino Y; Koide H J Lab Clin Med; 1994 May; 123(5):763-8. PubMed ID: 8195682 [TBL] [Abstract][Full Text] [Related]
5. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis. Ebihara I; Nakamura T; Tomino Y; Koide H Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058 [TBL] [Abstract][Full Text] [Related]
6. Expression of a nonmuscle myosin heavy chain in glomerular cells differentiates various types of glomerular disease in rats. Hiroi J; Kimura K; Aikawa M; Tojo A; Suzuki Y; Nagamatsu T; Omata M; Yazaki Y; Nagai R Kidney Int; 1996 May; 49(5):1231-41. PubMed ID: 8731086 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II enhances glomerular expression of a nonmuscle myosin heavy chain, SMemb, with extracellular matrix accumulation. Mise N; Kimura K; Kurabayashi M; Nagai R; Okuda T; Ohba S; Suzuki N; Miyashita K; Kamijo A; Tojo A; Goto A; Omata M Nephron; 2002 Apr; 90(4):477-83. PubMed ID: 11961408 [TBL] [Abstract][Full Text] [Related]
8. Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli. Nakamura T; Ebihara I; Fukui M; Tomino Y; Koide H Diabetes; 1995 Aug; 44(8):895-9. PubMed ID: 7621993 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes. Makino H; Kashihara N; Sugiyama H; Kanao K; Sekikawa T; Okamoto K; Maeshima Y; Ota Z; Nagai R Diabetes; 1996 Apr; 45(4):488-95. PubMed ID: 8603771 [TBL] [Abstract][Full Text] [Related]
10. Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity. Duggan KA; Hodge G; Makarious MM; Charlesworth JA Clin Sci (Lond); 1998 May; 94(5):511-6. PubMed ID: 9682674 [TBL] [Abstract][Full Text] [Related]
11. Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. Nakamura T; Takahashi T; Fukui M; Ebihara I; Osada S; Tomino Y; Koide H J Am Soc Nephrol; 1995 Jan; 5(7):1492-7. PubMed ID: 7703388 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor beta receptor expression in experimental diabetes in rats. Hill C; Logan A; Smith C; Grønbaek H; Flyvbjerg A Diabetologia; 2001 Apr; 44(4):495-500. PubMed ID: 11357481 [TBL] [Abstract][Full Text] [Related]
13. Hyperlipidaemia and the progression of nephropathy in OLETF rats: effect of angiotensin-converting enzyme inhibitor, enalapril. Sugimoto K; Tsuruoka S; Fujimura A Clin Exp Pharmacol Physiol; 1999 Aug; 26(8):601-7. PubMed ID: 10474773 [TBL] [Abstract][Full Text] [Related]
15. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Aikawa M; Sivam PN; Kuro-o M; Kimura K; Nakahara K; Takewaki S; Ueda M; Yamaguchi H; Yazaki Y; Periasamy M Circ Res; 1993 Dec; 73(6):1000-12. PubMed ID: 7916668 [TBL] [Abstract][Full Text] [Related]
16. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats. Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage. Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658 [TBL] [Abstract][Full Text] [Related]
18. Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy. Cooper ME; Allen TJ; O'Brien RC; Papazoglou D; Clarke BE; Jerums G; Doyle AE Diabetes; 1990 Dec; 39(12):1575-9. PubMed ID: 2245881 [TBL] [Abstract][Full Text] [Related]
19. Bound thrombin-induced upregulation of myosin heavy chain isoform, SMemb messenger RNA expression in cultured rabbit vascular smooth muscle cells. Shimada S; Sunagawa M; Nakamura M; Kosugi T Int J Tissue React; 2003; 25(4):137-48. PubMed ID: 15244319 [TBL] [Abstract][Full Text] [Related]
20. Alteration of growth-related proto-oncogene expression in diabetic glomeruli by a specific endothelin receptor A antagonist. Nakamura T; Ebihara I; Tomino Y; Koide H Nephrol Dial Transplant; 1996 Aug; 11(8):1528-31. PubMed ID: 8856205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]